Publication | Closed Access
Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer
194
Citations
36
References
2011
Year
The results show that TH-302 has broad antitumor activity and selectively targets hypoxic tumor tissues.
| Year | Citations | |
|---|---|---|
Page 1
Page 1